Results for this period
Third quarter1 October 2025 to 30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Although the transfer of Micron to an equity-method affiliate was a factor contributing to the decrease, net sales increased mainly because 2 customer projects with particularly large contract values for the electronic medical record system went live during the interim period. Operating income and ordinary income increased in line with the increase in electronic medical record system sales, and net income also increased despite the impairment loss recorded for Doctor Connect.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 October 2025 to 30 June 2026 |
| Net Sales | ¥13,292 million (YoY +7.9%) |
| Operating profit | ¥1,364 million (YoY +14.1%) |
| Ordinary income | ¥1,384 million (YoY +14.9%) |
| Profit attributable to owners of the parent | ¥685 million (YoY +4.6%) |
| Net income per share | ¥41.14 |
| Equity ratio | End of the current fiscal period 71 / End of previous period 65.2 |
| Total assets | ¥11,492 million |
| Net assets | ¥8,687 million |
| Full-year earnings forecast | Net Sales ¥16,000 million (YoY +1.1%) / Operating profit ¥1,600 million (YoY +13.3%) / Ordinary income ¥1,600 million (YoY +12.1%) / Net income ¥870 million (YoY -44.2%) |
| Annual Dividend Forecast | ¥52 → ¥0（-100.0%） |
| Segment revenue | Healthcare Solutions business ¥12,917,201 thousand (YoY +8.3%), Marketing Solutions Business ¥375,605 thousand (YoY -5.6%) |
| Segment profit | Healthcare Solutions business ¥1,371,344 thousand (YoY +15.0%), Marketing Solutions Business ¥22,593 thousand (YoY +497.0%) |
| Orders received and order backlog | Orders received ¥11,066 million (YoY -0.1%) / Order backlog ¥3,881 million (YoY -24.7%) |
| Depreciation and amortization | ¥443,029 thousand |
| Impairment loss | ¥148,467 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income No / Extraordinary loss Impairment Losses ¥148,467 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | No |
| Material subsequent events | Regarding the tender offer by SK-03株式会社 for the Company’s common shares, the Company resolved to express an opinion in favor of the tender offer while maintaining a neutral position and leaving the decision on whether to tender shares to shareholders. The Company plans not to pay a year-end dividend for the fiscal year ending September 2026, subject to completion of the tender offer. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | None (対象者：Not applicable) |
| Issued Shares at Period-End | 17,039,400 |
| Treasury Shares at Period-End | 363,863 |
| Factors Behind Changes in Business Performance | Although the transfer of Micron to an equity-method affiliate was a factor contributing to the decrease, net sales increased mainly because 2 customer projects with particularly large contract values for the electronic medical record system went live during the interim period. Operating income and ordinary income increased in line with the increase in electronic medical record system sales, and net income also increased despite the impairment loss recorded for Doctor Connect. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales increased mainly because 2 electronic medical record system projects with particularly large contract values went live during the interim period, resulting in increases in operating income and ordinary income. Although an impairment loss was recorded for Doctor Connect, net income also increased due to the aforementioned increases in profit. The decision to pay no year-end dividend is intended, among other reasons, to avoid economic disparities among shareholders following completion of the tender offer.